Psyomics secures £4M to revolutionise mental health assessment with AI — TFN

Psyomics, a UK-based mental health technology company, has secured £4 million in funding led by Parkwalk Advisors. The investment will be used to develop additional capabilities for children and young people in Censeo, Psyomics' AI-informed medical device, including triage and assessment plus neurodiversity screening. Psyomics aims to revolutionize mental health assessment and treatment in the UK and globally.

Psyomics Secures £4 Million for AI-Powered Mental Health Assessment

Psyomics is a UK-based mental health technology company that has developed Censeo, an AI-informed medical device for mental health assessment, diagnosis, triage, and treatment. It was spun out from Cambridge University, collaborating with leading neurotechnology and clinical experts.

A UK-based mental health technology company developing AI-informed medical devices for mental health assessment and treatment.

a year ago

Psyomics Secures £4 Million for AI-Powered Mental Health Assessment

Covered on